Royal Bank Of Canada Palatin Technologies Inc Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.5 $0 - $0	-1 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.37 - $0.54 $739 - $1,079	-1,999 Reduced 99.95%	1 $0
Q4 2021 Feb 14, 2022	BUY	$0.34 - $0.86 $523 - $1,325	1,541 Added 335.73%	2,000 $1,000
Q3 2021 Nov 15, 2021	BUY	$0.44 - $0.63 $201 - $289	459 New	459 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.